

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.76535201 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 9.63170801 |
| 3 | angiotensin maturation (GO:0002003) | 8.41685171 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 8.00327193 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.38168976 |
| 6 | NADH metabolic process (GO:0006734) | 6.79426926 |
| 7 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.53338819 |
| 8 | phospholipid efflux (GO:0033700) | 6.49875584 |
| 9 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.47152582 |
| 10 | regulation of cholesterol esterification (GO:0010872) | 6.44156252 |
| 11 | regulation of triglyceride catabolic process (GO:0010896) | 6.16818616 |
| 12 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.10059863 |
| 13 | flavonoid metabolic process (GO:0009812) | 5.85265528 |
| 14 | drug catabolic process (GO:0042737) | 5.74560632 |
| 15 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.72801237 |
| 16 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.72801237 |
| 17 | plasma lipoprotein particle assembly (GO:0034377) | 5.71717990 |
| 18 | fructose metabolic process (GO:0006000) | 5.41057525 |
| 19 | regulation of cellular extravasation (GO:0002691) | 5.40962257 |
| 20 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.39360403 |
| 21 | endocrine process (GO:0050886) | 5.39360403 |
| 22 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.39360403 |
| 23 | vitamin A metabolic process (GO:0006776) | 5.37395135 |
| 24 | cholesterol efflux (GO:0033344) | 5.34936992 |
| 25 | protein-lipid complex assembly (GO:0065005) | 5.32610494 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 5.29869815 |
| 27 | regulation of bile acid biosynthetic process (GO:0070857) | 5.23511020 |
| 28 | reverse cholesterol transport (GO:0043691) | 5.22872935 |
| 29 | bile acid and bile salt transport (GO:0015721) | 5.06727542 |
| 30 | negative regulation of sterol transport (GO:0032372) | 5.05992535 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 5.05992535 |
| 32 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.05551445 |
| 33 | lipoprotein metabolic process (GO:0042157) | 4.99695219 |
| 34 | virion attachment to host cell (GO:0019062) | 4.88195335 |
| 35 | adhesion of symbiont to host cell (GO:0044650) | 4.88195335 |
| 36 | regulation of cGMP biosynthetic process (GO:0030826) | 4.85864778 |
| 37 | regulation of systemic arterial blood pressure (GO:0003073) | 4.85823640 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.78055131 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.78055131 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.78055131 |
| 41 | cholesterol homeostasis (GO:0042632) | 4.59404439 |
| 42 | sterol homeostasis (GO:0055092) | 4.53696793 |
| 43 | hormone catabolic process (GO:0042447) | 4.52373327 |
| 44 | urea metabolic process (GO:0019627) | 4.51556684 |
| 45 | urea cycle (GO:0000050) | 4.51556684 |
| 46 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.46916185 |
| 47 | antibacterial humoral response (GO:0019731) | 4.32719355 |
| 48 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.23698676 |
| 49 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.23698676 |
| 50 | adhesion of symbiont to host (GO:0044406) | 4.22157568 |
| 51 | glycolipid catabolic process (GO:0019377) | 4.21080577 |
| 52 | sterol transport (GO:0015918) | 4.20338359 |
| 53 | cholesterol transport (GO:0030301) | 4.20338359 |
| 54 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.19093439 |
| 55 | antimicrobial humoral response (GO:0019730) | 4.15568548 |
| 56 | glycosphingolipid catabolic process (GO:0046479) | 4.13704300 |
| 57 | plasma lipoprotein particle organization (GO:0071827) | 4.13462691 |
| 58 | digestive system process (GO:0022600) | 4.11722886 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.10380667 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.10380667 |
| 61 | nitrogen cycle metabolic process (GO:0071941) | 4.08660175 |
| 62 | * digestion (GO:0007586) | 4.07776728 |
| 63 | regulation of vitamin metabolic process (GO:0030656) | 4.05710540 |
| 64 | positive regulation of lipid catabolic process (GO:0050996) | 4.05649746 |
| 65 | regulation of cGMP metabolic process (GO:0030823) | 4.05092853 |
| 66 | protein-lipid complex subunit organization (GO:0071825) | 4.00965132 |
| 67 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.00833604 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 3.99175974 |
| 69 | renal system process involved in regulation of blood volume (GO:0001977) | 3.98139547 |
| 70 | homocysteine metabolic process (GO:0050667) | 3.93239716 |
| 71 | modified amino acid transport (GO:0072337) | 3.91320910 |
| 72 | glucose 6-phosphate metabolic process (GO:0051156) | 3.88935401 |
| 73 | fat-soluble vitamin metabolic process (GO:0006775) | 3.87621065 |
| 74 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.86496384 |
| 75 | alpha-linolenic acid metabolic process (GO:0036109) | 3.84131836 |
| 76 | mRNA modification (GO:0016556) | 3.77830959 |
| 77 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.74787937 |
| 78 | positive regulation of pseudopodium assembly (GO:0031274) | 3.74725975 |
| 79 | phospholipid homeostasis (GO:0055091) | 3.74227497 |
| 80 | cellular response to nitric oxide (GO:0071732) | 3.72352160 |
| 81 | plasma lipoprotein particle clearance (GO:0034381) | 3.70732332 |
| 82 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.69558366 |
| 83 | drug metabolic process (GO:0017144) | 3.68966182 |
| 84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68662710 |
| 85 | arginine metabolic process (GO:0006525) | 3.66497782 |
| 86 | cysteine metabolic process (GO:0006534) | 3.66239250 |
| 87 | cellular glucuronidation (GO:0052695) | 3.64226466 |
| 88 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.63791611 |
| 89 | vitamin transmembrane transport (GO:0035461) | 3.63593719 |
| 90 | L-phenylalanine catabolic process (GO:0006559) | 3.62724032 |
| 91 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.62724032 |
| 92 | vitamin transport (GO:0051180) | 3.62466642 |
| 93 | cytidine deamination (GO:0009972) | 3.62434715 |
| 94 | cytidine metabolic process (GO:0046087) | 3.62434715 |
| 95 | cytidine catabolic process (GO:0006216) | 3.62434715 |
| 96 | diacylglycerol metabolic process (GO:0046339) | 3.62148859 |
| 97 | lipoprotein transport (GO:0042953) | 3.61494157 |
| 98 | drinking behavior (GO:0042756) | 3.58943070 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.58478053 |
| 100 | L-phenylalanine metabolic process (GO:0006558) | 3.58478053 |
| 101 | actin filament depolymerization (GO:0030042) | 3.54333517 |
| 102 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.53912406 |
| 103 | killing of cells of other organism (GO:0031640) | 3.53723184 |
| 104 | disruption of cells of other organism (GO:0044364) | 3.53723184 |
| 105 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.52811830 |
| 106 | exogenous drug catabolic process (GO:0042738) | 3.52073189 |
| 107 | bile acid metabolic process (GO:0008206) | 3.51317011 |
| 108 | cGMP biosynthetic process (GO:0006182) | 3.47174310 |
| 109 | sulfur amino acid catabolic process (GO:0000098) | 3.46847142 |
| 110 | lipid homeostasis (GO:0055088) | 3.45437743 |
| 111 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.41697689 |
| 112 | ceramide catabolic process (GO:0046514) | 3.40106444 |
| 113 | vitamin biosynthetic process (GO:0009110) | 3.40044429 |
| 114 | regulation of cholesterol transport (GO:0032374) | 3.37810932 |
| 115 | regulation of sterol transport (GO:0032371) | 3.37810932 |
| 116 | drug transmembrane transport (GO:0006855) | 3.37514260 |
| 117 | midgut development (GO:0007494) | 3.36834813 |
| 118 | response to nitric oxide (GO:0071731) | 3.35020839 |
| 119 | glycosylceramide metabolic process (GO:0006677) | 3.34998708 |
| 120 | regulation of pseudopodium assembly (GO:0031272) | 3.34680849 |
| 121 | sulfate transmembrane transport (GO:1902358) | 3.33210152 |
| 122 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.32489900 |
| 123 | drug transport (GO:0015893) | 3.27454680 |
| 124 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.26779759 |
| 125 | peptide catabolic process (GO:0043171) | 3.26644895 |
| 126 | peptide hormone processing (GO:0016486) | 3.25616293 |
| 127 | aromatic amino acid family catabolic process (GO:0009074) | 3.25389463 |
| 128 | glucuronate metabolic process (GO:0019585) | 3.25082451 |
| 129 | uronic acid metabolic process (GO:0006063) | 3.25082451 |
| 130 | epoxygenase P450 pathway (GO:0019373) | 3.24774421 |
| 131 | regulation of protein glycosylation (GO:0060049) | 3.24730079 |
| 132 | positive regulation of cGMP metabolic process (GO:0030825) | 3.23552437 |
| 133 | sulfation (GO:0051923) | 3.23399924 |
| 134 | glycerol metabolic process (GO:0006071) | 3.22355408 |
| 135 | cellular response to reactive nitrogen species (GO:1902170) | 3.18073225 |
| 136 | sphingomyelin metabolic process (GO:0006684) | 3.15387321 |
| 137 | cobalamin metabolic process (GO:0009235) | 3.14998505 |
| 138 | sphingolipid catabolic process (GO:0030149) | 3.13610389 |
| 139 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.13136597 |
| 140 | amino-acid betaine metabolic process (GO:0006577) | 3.12260921 |
| 141 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.09877074 |
| 142 | transcytosis (GO:0045056) | 3.06409203 |
| 143 | vitamin D metabolic process (GO:0042359) | 3.05485047 |
| 144 | negative regulation of digestive system process (GO:0060457) | 3.04954619 |
| 145 | cellular ketone body metabolic process (GO:0046950) | 3.04954369 |
| 146 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.03615313 |
| 147 | nucleobase catabolic process (GO:0046113) | 3.02739306 |
| 148 | alkaloid metabolic process (GO:0009820) | 3.02645923 |
| 149 | bile acid biosynthetic process (GO:0006699) | 3.01440427 |
| 150 | response to phenylpropanoid (GO:0080184) | 2.98604091 |
| 151 | regulation of triglyceride metabolic process (GO:0090207) | 2.98578226 |
| 152 | kynurenine metabolic process (GO:0070189) | 2.97331727 |
| 153 | lysine catabolic process (GO:0006554) | 2.96847066 |
| 154 | lysine metabolic process (GO:0006553) | 2.96847066 |
| 155 | heme transport (GO:0015886) | 2.96350403 |
| 156 | regulation of lipoprotein metabolic process (GO:0050746) | 2.95203172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.78342570 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.77211578 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.67282412 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.38092637 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.83126874 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.50893497 |
| 7 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.04615706 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.79252143 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.21850399 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.13519289 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01907777 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.01362622 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.91429261 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.90717751 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.87735211 |
| 16 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.55184389 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.22307081 |
| 18 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.05867557 |
| 19 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.97085626 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.95419091 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.78701412 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74923286 |
| 23 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69066803 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.68396296 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65187013 |
| 26 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.63564135 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62145744 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60778560 |
| 29 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54975190 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47343456 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42585348 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32539850 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.32467457 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31659176 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29588448 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28294664 |
| 37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27823447 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26797500 |
| 39 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25304449 |
| 40 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24890374 |
| 41 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24660082 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21208833 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18827918 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18713064 |
| 45 | GATA2_19941826_ChIP-Seq_K562_Human | 1.17128214 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13922073 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12843258 |
| 48 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11523981 |
| 49 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09029585 |
| 50 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.08527734 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06747963 |
| 52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05827160 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05470696 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04181035 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04078634 |
| 56 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.03245673 |
| 57 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02907666 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02684865 |
| 59 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.02227463 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01900844 |
| 61 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01897415 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01481301 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01048811 |
| 64 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99161546 |
| 65 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98790283 |
| 66 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98549849 |
| 67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97592989 |
| 68 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96615243 |
| 69 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.96450195 |
| 70 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96087050 |
| 71 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95620366 |
| 72 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94796215 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93758748 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93632551 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93055323 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92021447 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88775756 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88640786 |
| 79 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88249463 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87498466 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86232390 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86074015 |
| 83 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.84960455 |
| 84 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.84416610 |
| 85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84411628 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83904834 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83865380 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83549888 |
| 89 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83125091 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.82942522 |
| 91 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82589337 |
| 92 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82524455 |
| 93 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.82458929 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.82324155 |
| 95 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.82103355 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80323676 |
| 97 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79932324 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79835500 |
| 99 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79818624 |
| 100 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.79462175 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79071314 |
| 102 | NCOR_22424771_ChIP-Seq_293T_Human | 0.79046997 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78195828 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77312135 |
| 105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77115439 |
| 106 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.75120946 |
| 107 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.75120946 |
| 108 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.74637275 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74210254 |
| 110 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.73804131 |
| 111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73640560 |
| 112 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.73539793 |
| 113 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.73375472 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.73358379 |
| 115 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.73227440 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.72987025 |
| 117 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72195744 |
| 118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71405240 |
| 119 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.70819361 |
| 120 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.70647399 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.69052845 |
| 122 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.68885643 |
| 123 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.67781605 |
| 124 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.67303207 |
| 125 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.66260368 |
| 126 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66039451 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65816556 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65785524 |
| 129 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65365532 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.65337547 |
| 131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65039479 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64750139 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.64364846 |
| 134 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.63764047 |
| 135 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63340370 |
| 136 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.63083823 |
| 137 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.62719567 |
| 138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.60490386 |
| 139 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.60237061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.73295099 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.13642905 |
| 3 | MP0001666_abnormal_nutrient_absorption | 5.35796776 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.06556104 |
| 5 | MP0009840_abnormal_foam_cell | 4.50672511 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.27651689 |
| 7 | MP0005365_abnormal_bile_salt | 4.16532013 |
| 8 | MP0003252_abnormal_bile_duct | 3.87309927 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.36885802 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.87674896 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.66502244 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.49111766 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.43777956 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.29894057 |
| 15 | MP0002822_catalepsy | 2.25370576 |
| 16 | MP0000462_abnormal_digestive_system | 2.07219239 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.02257207 |
| 18 | MP0005332_abnormal_amino_acid | 1.91480327 |
| 19 | MP0005409_darkened_coat_color | 1.88579193 |
| 20 | MP0009697_abnormal_copulation | 1.70123826 |
| 21 | MP0003866_abnormal_defecation | 1.69203403 |
| 22 | MP0005084_abnormal_gallbladder_morpholo | 1.67697822 |
| 23 | MP0000609_abnormal_liver_physiology | 1.58492226 |
| 24 | * MP0002118_abnormal_lipid_homeostasis | 1.54100242 |
| 25 | MP0004147_increased_porphyrin_level | 1.47686508 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.36176171 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.35696817 |
| 28 | MP0005670_abnormal_white_adipose | 1.35117813 |
| 29 | MP0003878_abnormal_ear_physiology | 1.35015944 |
| 30 | MP0005377_hearing/vestibular/ear_phenot | 1.35015944 |
| 31 | MP0002254_reproductive_system_inflammat | 1.30947221 |
| 32 | MP0001188_hyperpigmentation | 1.30601468 |
| 33 | MP0003868_abnormal_feces_composition | 1.27362163 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.25830004 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.25544796 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.23505144 |
| 37 | MP0001663_abnormal_digestive_system | 1.22320390 |
| 38 | MP0005381_digestive/alimentary_phenotyp | 1.21502133 |
| 39 | MP0000538_abnormal_urinary_bladder | 1.21065508 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.20182149 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.17370987 |
| 42 | MP0001664_abnormal_digestion | 1.12617871 |
| 43 | MP0005451_abnormal_body_composition | 1.12191093 |
| 44 | MP0004858_abnormal_nervous_system | 1.11119980 |
| 45 | MP0004043_abnormal_pH_regulation | 1.10442731 |
| 46 | MP0001764_abnormal_homeostasis | 1.10392679 |
| 47 | MP0004270_analgesia | 1.09142713 |
| 48 | MP0001873_stomach_inflammation | 1.04060842 |
| 49 | MP0005535_abnormal_body_temperature | 1.03686645 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.03610633 |
| 51 | MP0005083_abnormal_biliary_tract | 1.03344350 |
| 52 | MP0002876_abnormal_thyroid_physiology | 1.03215992 |
| 53 | MP0000537_abnormal_urethra_morphology | 1.01658373 |
| 54 | MP0000477_abnormal_intestine_morphology | 1.01361462 |
| 55 | MP0002796_impaired_skin_barrier | 0.99368915 |
| 56 | MP0009379_abnormal_foot_pigmentation | 0.98474438 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96708137 |
| 58 | * MP0005448_abnormal_energy_balance | 0.94638652 |
| 59 | MP0002396_abnormal_hematopoietic_system | 0.93688274 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 0.91140171 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 0.81533120 |
| 62 | MP0003718_maternal_effect | 0.80702034 |
| 63 | MP0009785_altered_susceptibility_to | 0.80120112 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 0.79392431 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 0.79352113 |
| 66 | MP0003724_increased_susceptibility_to | 0.77535360 |
| 67 | MP0006054_spinal_hemorrhage | 0.75349154 |
| 68 | MP0001835_abnormal_antigen_presentation | 0.74724039 |
| 69 | MP0000604_amyloidosis | 0.73088274 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 0.72844029 |
| 71 | MP0008872_abnormal_physiological_respon | 0.72543375 |
| 72 | MP0005266_abnormal_metabolism | 0.72491966 |
| 73 | MP0002166_altered_tumor_susceptibility | 0.72487335 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.71698091 |
| 75 | MP0001485_abnormal_pinna_reflex | 0.70187941 |
| 76 | MP0005174_abnormal_tail_pigmentation | 0.69707241 |
| 77 | * MP0009642_abnormal_blood_homeostasis | 0.69400196 |
| 78 | MP0009053_abnormal_anal_canal | 0.68329903 |
| 79 | MP0000490_abnormal_crypts_of | 0.67480501 |
| 80 | MP0005166_decreased_susceptibility_to | 0.66109560 |
| 81 | MP0009764_decreased_sensitivity_to | 0.65019125 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.64548475 |
| 83 | MP0004947_skin_inflammation | 0.63829813 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.63640070 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.62658160 |
| 86 | MP0005025_abnormal_response_to | 0.61691101 |
| 87 | MP0001790_abnormal_immune_system | 0.60501865 |
| 88 | MP0005387_immune_system_phenotype | 0.60501865 |
| 89 | MP0006082_CNS_inflammation | 0.60069858 |
| 90 | * MP0000598_abnormal_liver_morphology | 0.59984608 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.59480922 |
| 92 | MP0003195_calcinosis | 0.59021725 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.57851496 |
| 94 | MP0009384_cardiac_valve_regurgitation | 0.56171786 |
| 95 | MP0008469_abnormal_protein_level | 0.56081341 |
| 96 | MP0003638_abnormal_response/metabolism_ | 0.54494058 |
| 97 | MP0000467_abnormal_esophagus_morphology | 0.54258718 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.54135942 |
| 99 | MP0005501_abnormal_skin_physiology | 0.52300046 |
| 100 | MP0002971_abnormal_brown_adipose | 0.51647664 |
| 101 | MP0002148_abnormal_hypersensitivity_rea | 0.49090050 |
| 102 | MP0001849_ear_inflammation | 0.47328082 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 0.47216946 |
| 104 | MP0002098_abnormal_vibrissa_morphology | 0.46437961 |
| 105 | MP0005671_abnormal_response_to | 0.46114064 |
| 106 | MP0008873_increased_physiological_sensi | 0.46056348 |
| 107 | MP0001756_abnormal_urination | 0.45989776 |
| 108 | MP0002006_tumorigenesis | 0.45813493 |
| 109 | MP0009333_abnormal_splenocyte_physiolog | 0.45510058 |
| 110 | * MP0002078_abnormal_glucose_homeostasis | 0.45483592 |
| 111 | MP0009115_abnormal_fat_cell | 0.44898562 |
| 112 | MP0010678_abnormal_skin_adnexa | 0.44378241 |
| 113 | MP0003436_decreased_susceptibility_to | 0.44298235 |
| 114 | MP0003283_abnormal_digestive_organ | 0.44188055 |
| 115 | MP0004484_altered_response_of | 0.44165009 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.43600681 |
| 117 | MP0009780_abnormal_chondrocyte_physiolo | 0.43579405 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.43455106 |
| 119 | MP0009763_increased_sensitivity_to | 0.43454641 |
| 120 | * MP0003953_abnormal_hormone_level | 0.43052121 |
| 121 | MP0001800_abnormal_humoral_immune | 0.42335646 |
| 122 | MP0003879_abnormal_hair_cell | 0.40438985 |
| 123 | MP0005464_abnormal_platelet_physiology | 0.39171761 |
| 124 | MP0005408_hypopigmentation | 0.38979792 |
| 125 | MP0001881_abnormal_mammary_gland | 0.36811718 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.35467894 |
| 127 | MP0000249_abnormal_blood_vessel | 0.34823247 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.33599955 |
| 129 | MP0000427_abnormal_hair_cycle | 0.32775180 |
| 130 | MP0006138_congestive_heart_failure | 0.31098207 |
| 131 | MP0000579_abnormal_nail_morphology | 0.29570272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 7.99976412 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.09125380 |
| 3 | Ileus (HP:0002595) | 6.43541827 |
| 4 | Acanthocytosis (HP:0001927) | 5.96458608 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 5.52985879 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 5.39267425 |
| 7 | Hypolipoproteinemia (HP:0010981) | 5.26422110 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.24476032 |
| 9 | Xanthomatosis (HP:0000991) | 5.17620718 |
| 10 | Malnutrition (HP:0004395) | 5.06911600 |
| 11 | Fat malabsorption (HP:0002630) | 5.04019525 |
| 12 | Hydroxyprolinuria (HP:0003080) | 4.83373904 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 4.83373904 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.41288415 |
| 15 | Hyperglycinuria (HP:0003108) | 4.38780120 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 4.10434255 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.96214779 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86424524 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.76381591 |
| 20 | Epidermoid cyst (HP:0200040) | 3.75236690 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.73732157 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70512590 |
| 23 | Poikilocytosis (HP:0004447) | 3.67620815 |
| 24 | Deep venous thrombosis (HP:0002625) | 3.66712769 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.57979967 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.57979967 |
| 27 | Hyperammonemia (HP:0001987) | 3.53945496 |
| 28 | Hypercholesterolemia (HP:0003124) | 3.53348454 |
| 29 | Decreased circulating renin level (HP:0003351) | 3.51269301 |
| 30 | Thin bony cortex (HP:0002753) | 3.42587320 |
| 31 | Pigmentary retinal degeneration (HP:0001146) | 3.40443267 |
| 32 | Congenital sensorineural hearing impairment (HP:0008527) | 3.30791651 |
| 33 | Hyperactive renin-angiotensin system (HP:0000841) | 3.26807756 |
| 34 | Metabolic alkalosis (HP:0200114) | 3.22585056 |
| 35 | Cupped ribs (HP:0000887) | 3.20492867 |
| 36 | Alkalosis (HP:0001948) | 3.20048326 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 3.17322935 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 3.12424991 |
| 39 | Widely patent fontanelles and sutures (HP:0004492) | 3.09115132 |
| 40 | Chronic diarrhea (HP:0002028) | 3.07403616 |
| 41 | Hypoglycemic coma (HP:0001325) | 3.02232740 |
| 42 | Posterior subcapsular cataract (HP:0007787) | 2.97800350 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 2.95481347 |
| 44 | Glycosuria (HP:0003076) | 2.95481347 |
| 45 | Abdominal distention (HP:0003270) | 2.93512507 |
| 46 | Increased purine levels (HP:0004368) | 2.92043425 |
| 47 | Hyperuricemia (HP:0002149) | 2.92043425 |
| 48 | Hyperbilirubinemia (HP:0002904) | 2.88326229 |
| 49 | Enlarged epiphyses (HP:0010580) | 2.87001859 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 2.84509261 |
| 51 | Metabolic acidosis (HP:0001942) | 2.84070769 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.82486749 |
| 53 | Hypophosphatemia (HP:0002148) | 2.81103930 |
| 54 | Potter facies (HP:0002009) | 2.79432999 |
| 55 | Facial shape deformation (HP:0011334) | 2.79432999 |
| 56 | Abnormality of renin-angiotensin system (HP:0000847) | 2.73491260 |
| 57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.71593952 |
| 58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.70020736 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.68932440 |
| 60 | Villous atrophy (HP:0011473) | 2.63809362 |
| 61 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.63809362 |
| 62 | Abnormal urine phosphate concentration (HP:0012599) | 2.60626164 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.57600868 |
| 64 | Abnormality of vitamin metabolism (HP:0100508) | 2.55596779 |
| 65 | Abnormality of the common coagulation pathway (HP:0010990) | 2.53095481 |
| 66 | Ketosis (HP:0001946) | 2.52245197 |
| 67 | Reticulocytosis (HP:0001923) | 2.51742537 |
| 68 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.49808358 |
| 69 | Nephrolithiasis (HP:0000787) | 2.49559918 |
| 70 | Gastrointestinal dysmotility (HP:0002579) | 2.47859513 |
| 71 | Cholecystitis (HP:0001082) | 2.47334661 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.47334661 |
| 73 | Increased mean platelet volume (HP:0011877) | 2.47096398 |
| 74 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44681936 |
| 75 | Mesangial abnormality (HP:0001966) | 2.43731278 |
| 76 | Delayed epiphyseal ossification (HP:0002663) | 2.43644987 |
| 77 | Hyperparathyroidism (HP:0000843) | 2.42255913 |
| 78 | Abnormality of the costochondral junction (HP:0000919) | 2.37926974 |
| 79 | Ketoacidosis (HP:0001993) | 2.37203270 |
| 80 | Steatorrhea (HP:0002570) | 2.35466891 |
| 81 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.35087823 |
| 82 | Focal segmental glomerulosclerosis (HP:0000097) | 2.32716144 |
| 83 | Abnormality of vitamin B metabolism (HP:0004340) | 2.28395097 |
| 84 | Complement deficiency (HP:0004431) | 2.28361698 |
| 85 | Pancreatitis (HP:0001733) | 2.26195945 |
| 86 | Hypotension (HP:0002615) | 2.25481225 |
| 87 | Confusion (HP:0001289) | 2.24866314 |
| 88 | Cerebral palsy (HP:0100021) | 2.22868160 |
| 89 | Amyloidosis (HP:0011034) | 2.21204230 |
| 90 | Dehydration (HP:0001944) | 2.19199484 |
| 91 | Skin nodule (HP:0200036) | 2.18138135 |
| 92 | Abnormal platelet volume (HP:0011876) | 2.14192657 |
| 93 | Late onset (HP:0003584) | 2.12876916 |
| 94 | Hyperglycinemia (HP:0002154) | 2.12227930 |
| 95 | Polycythemia (HP:0001901) | 2.10711058 |
| 96 | Increased IgE level (HP:0003212) | 2.09655045 |
| 97 | Abnormality of magnesium homeostasis (HP:0004921) | 2.09100663 |
| 98 | Hyperphosphaturia (HP:0003109) | 2.08932609 |
| 99 | Symptomatic seizures (HP:0011145) | 2.08537424 |
| 100 | Abnormal glucose tolerance (HP:0001952) | 2.07884656 |
| 101 | Subcapsular cataract (HP:0000523) | 2.04426669 |
| 102 | Nausea (HP:0002018) | 2.02800600 |
| 103 | Protuberant abdomen (HP:0001538) | 2.01835300 |
| 104 | Cholelithiasis (HP:0001081) | 2.01275884 |
| 105 | Abnormality of the intrinsic pathway (HP:0010989) | 1.99572745 |
| 106 | Abnormal gallbladder morphology (HP:0012437) | 1.99319504 |
| 107 | Gout (HP:0001997) | 1.98354347 |
| 108 | Dicarboxylic aciduria (HP:0003215) | 1.97694239 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97694239 |
| 110 | Hemorrhage of the eye (HP:0011885) | 1.97171129 |
| 111 | Vascular calcification (HP:0004934) | 1.97050694 |
| 112 | Sensorimotor neuropathy (HP:0007141) | 1.95928368 |
| 113 | Irritability (HP:0000737) | 1.95229745 |
| 114 | Renal tubular acidosis (HP:0001947) | 1.95160639 |
| 115 | Hypoglycemic seizures (HP:0002173) | 1.94933680 |
| 116 | Palpitations (HP:0001962) | 1.94904194 |
| 117 | Hyperphosphatemia (HP:0002905) | 1.93576406 |
| 118 | Gingivitis (HP:0000230) | 1.91613979 |
| 119 | Esophageal varix (HP:0002040) | 1.87298424 |
| 120 | Abnormal albumin level (HP:0012116) | 1.86475910 |
| 121 | Hypoalbuminemia (HP:0003073) | 1.86475910 |
| 122 | Abnormal cartilage morphology (HP:0002763) | 1.86327396 |
| 123 | Lethargy (HP:0001254) | 1.83485165 |
| 124 | Flat acetabular roof (HP:0003180) | 1.83108046 |
| 125 | Pustule (HP:0200039) | 1.82550370 |
| 126 | Proximal tubulopathy (HP:0000114) | 1.82480192 |
| 127 | Megaloblastic anemia (HP:0001889) | 1.81848796 |
| 128 | Abnormal biliary tract morphology (HP:0012440) | 1.81703985 |
| 129 | Renal tubular dysfunction (HP:0000124) | 1.81484818 |
| 130 | Goiter (HP:0000853) | 1.80181525 |
| 131 | Wide cranial sutures (HP:0010537) | 1.80031223 |
| 132 | Glomerulonephritis (HP:0000099) | 1.79991095 |
| 133 | Abnormality of methionine metabolism (HP:0010901) | 1.79303797 |
| 134 | Severe combined immunodeficiency (HP:0004430) | 1.77738763 |
| 135 | Joint hemorrhage (HP:0005261) | 1.77686910 |
| 136 | Combined immunodeficiency (HP:0005387) | 1.77465993 |
| 137 | Glomerulosclerosis (HP:0000096) | 1.74425831 |
| 138 | Nephritis (HP:0000123) | 1.71306479 |
| 139 | Metaphyseal irregularity (HP:0003025) | 1.70000188 |
| 140 | Hypocalcemia (HP:0002901) | 1.69146159 |
| 141 | Growth hormone excess (HP:0000845) | 1.68227024 |
| 142 | Hypokalemia (HP:0002900) | 1.67868784 |
| 143 | Chorioretinal atrophy (HP:0000533) | 1.67675985 |
| 144 | Multiple lipomas (HP:0001012) | 1.67291293 |
| 145 | Paresthesia (HP:0003401) | 1.67008900 |
| 146 | Hyperaldosteronism (HP:0000859) | 1.65805703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 9.37655281 |
| 2 | FRK | 6.53887408 |
| 3 | MST1R | 4.91876306 |
| 4 | MST4 | 4.55788235 |
| 5 | LMTK2 | 4.32856187 |
| 6 | GRK6 | 3.48230566 |
| 7 | PRKG2 | 3.03565588 |
| 8 | ERN1 | 2.80187332 |
| 9 | STK39 | 2.54931154 |
| 10 | NME1 | 2.53793563 |
| 11 | EPHA2 | 2.46275446 |
| 12 | RIPK1 | 2.46084304 |
| 13 | MAP3K10 | 2.37585567 |
| 14 | MAP2K2 | 2.32116202 |
| 15 | PTK6 | 2.28584556 |
| 16 | AKT3 | 2.19399439 |
| 17 | OXSR1 | 2.18135303 |
| 18 | MAP3K2 | 2.09547065 |
| 19 | NUAK1 | 1.94370334 |
| 20 | MAP3K12 | 1.78888808 |
| 21 | MET | 1.76034668 |
| 22 | EPHA3 | 1.66507208 |
| 23 | TNIK | 1.57331469 |
| 24 | EPHB2 | 1.54999071 |
| 25 | TAOK3 | 1.51521269 |
| 26 | PIK3CA | 1.41552297 |
| 27 | BCKDK | 1.32344386 |
| 28 | MYLK | 1.28500390 |
| 29 | EPHA4 | 1.24788597 |
| 30 | TESK1 | 1.24611009 |
| 31 | FGFR4 | 1.23481862 |
| 32 | MAP3K7 | 1.14954865 |
| 33 | TESK2 | 1.14943934 |
| 34 | STK24 | 1.14605545 |
| 35 | LATS1 | 1.12903381 |
| 36 | MAP2K6 | 1.07585271 |
| 37 | PRKAA2 | 1.05571497 |
| 38 | KSR2 | 1.04400917 |
| 39 | MAPK11 | 1.02222942 |
| 40 | ERBB2 | 1.01288720 |
| 41 | STK10 | 1.00876264 |
| 42 | NLK | 0.97997265 |
| 43 | ERBB4 | 0.97016979 |
| 44 | MAP3K11 | 0.96978763 |
| 45 | EPHB1 | 0.96168116 |
| 46 | SIK1 | 0.96065781 |
| 47 | TAOK1 | 0.94567817 |
| 48 | PTK2 | 0.93886534 |
| 49 | PIM1 | 0.91643646 |
| 50 | CASK | 0.90876936 |
| 51 | FGFR3 | 0.90325405 |
| 52 | DDR2 | 0.88361863 |
| 53 | MAP2K1 | 0.87370694 |
| 54 | BMPR2 | 0.86436601 |
| 55 | TBK1 | 0.85841348 |
| 56 | IRAK1 | 0.83969324 |
| 57 | BMX | 0.80846779 |
| 58 | PBK | 0.80523268 |
| 59 | INSRR | 0.78828927 |
| 60 | MATK | 0.78429529 |
| 61 | MAP3K8 | 0.77780886 |
| 62 | FER | 0.73433726 |
| 63 | PKN2 | 0.72817950 |
| 64 | TYK2 | 0.70892397 |
| 65 | PRKCI | 0.69799460 |
| 66 | MAP3K1 | 0.68691999 |
| 67 | MAP3K3 | 0.67904425 |
| 68 | TEC | 0.66865573 |
| 69 | CDC42BPA | 0.58565382 |
| 70 | PDPK1 | 0.57337661 |
| 71 | JAK1 | 0.55791412 |
| 72 | PRKAA1 | 0.55674115 |
| 73 | CSK | 0.54625183 |
| 74 | ADRBK2 | 0.54157063 |
| 75 | TTK | 0.53809600 |
| 76 | ICK | 0.50180381 |
| 77 | PAK4 | 0.47974280 |
| 78 | GRK1 | 0.47764581 |
| 79 | SYK | 0.47487570 |
| 80 | DYRK1B | 0.47463305 |
| 81 | MAP2K4 | 0.46699628 |
| 82 | CDK6 | 0.46419941 |
| 83 | IKBKE | 0.46256262 |
| 84 | DAPK2 | 0.44432183 |
| 85 | BTK | 0.44170837 |
| 86 | PRKACG | 0.43118854 |
| 87 | CAMK2G | 0.43084238 |
| 88 | PRPF4B | 0.43004368 |
| 89 | PIK3CG | 0.42018088 |
| 90 | YES1 | 0.41584874 |
| 91 | RIPK4 | 0.40875777 |
| 92 | CDK19 | 0.40662530 |
| 93 | PAK3 | 0.39236848 |
| 94 | CSF1R | 0.37960054 |
| 95 | PRKCA | 0.37359082 |
| 96 | JAK2 | 0.37202449 |
| 97 | PDK1 | 0.36343246 |
| 98 | KIT | 0.35186634 |
| 99 | IRAK3 | 0.35154152 |
| 100 | MAPK4 | 0.35032237 |
| 101 | PRKCQ | 0.34733066 |
| 102 | PDK2 | 0.33194486 |
| 103 | JAK3 | 0.32839423 |
| 104 | RET | 0.31960850 |
| 105 | LYN | 0.31290407 |
| 106 | LRRK2 | 0.30792746 |
| 107 | GSK3A | 0.30617463 |
| 108 | PRKCZ | 0.29711369 |
| 109 | CAMK2D | 0.29464764 |
| 110 | ERBB3 | 0.25979736 |
| 111 | PRKACA | 0.25850397 |
| 112 | SRC | 0.25720446 |
| 113 | IGF1R | 0.25639696 |
| 114 | CAMK2B | 0.25450217 |
| 115 | MELK | 0.25036432 |
| 116 | IRAK4 | 0.24958390 |
| 117 | LCK | 0.24571448 |
| 118 | ABL2 | 0.24123668 |
| 119 | ITK | 0.24071729 |
| 120 | NEK6 | 0.23929148 |
| 121 | TXK | 0.23708101 |
| 122 | PAK2 | 0.23141308 |
| 123 | STK3 | 0.22735793 |
| 124 | CAMK2A | 0.22230235 |
| 125 | KDR | 0.22193725 |
| 126 | DMPK | 0.21924405 |
| 127 | PRKCD | 0.21449583 |
| 128 | LIMK1 | 0.20086905 |
| 129 | SCYL2 | 0.20063650 |
| 130 | CSNK1A1 | 0.18674922 |
| 131 | MAP3K9 | 0.18623518 |
| 132 | MAP4K1 | 0.18344431 |
| 133 | PDGFRA | 0.18168075 |
| 134 | AKT2 | 0.18127530 |
| 135 | MAP3K14 | 0.17162828 |
| 136 | ROCK1 | 0.17028479 |
| 137 | FLT3 | 0.16773833 |
| 138 | FYN | 0.16011820 |
| 139 | MAPKAPK2 | 0.15428137 |
| 140 | TRIB3 | 0.14899336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Fat digestion and absorption_Homo sapiens_hsa04975 | 4.36134558 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.57199068 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.29076847 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.18104752 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95691243 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.64451336 |
| 7 | Mineral absorption_Homo sapiens_hsa04978 | 2.56814881 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.45273738 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36289083 |
| 10 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.35162718 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32882834 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 2.29609316 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.29603079 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.27374300 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.24938579 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.06731828 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.98107647 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.97895241 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.92233609 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.85514422 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.79027250 |
| 22 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75968987 |
| 23 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.64982106 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63063077 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57688341 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56891113 |
| 27 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.49391780 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.45347673 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44911856 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41964262 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39725398 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37172896 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36797549 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36453907 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36346427 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32397953 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.32041959 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.31656142 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31497130 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.29745809 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26448936 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23744096 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.23645579 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22019193 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18781417 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.18433476 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.17890480 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17224630 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15864054 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05712339 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02767295 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00816174 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99816258 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99128099 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95040700 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 0.91917022 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91157774 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88178151 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84920617 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83977482 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83237200 |
| 62 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76577286 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74816587 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74388513 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70126323 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69758535 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69587809 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69444121 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69317518 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69281675 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66169386 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65134495 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64284731 |
| 74 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.63348013 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59199456 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58604139 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57872138 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57597964 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51197455 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.50305331 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46637253 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44811165 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43075605 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43046603 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41562531 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.39085298 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.38665920 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37478027 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27697542 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.26899629 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24421022 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.18178782 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16788252 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15427139 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.15384721 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.15132274 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.14133648 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.14070182 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.13874580 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.13391535 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.12912410 |
| 102 | Insulin secretion_Homo sapiens_hsa04911 | 0.10290613 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09006158 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.08875922 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.08669847 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07939421 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.06940883 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.05617731 |
| 109 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.05570301 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04881004 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.04041458 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03255722 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.01908701 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | -0.1272514 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | -0.1104214 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0971642 |
| 117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0948352 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0891444 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0627669 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0467800 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0366792 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0103181 |
| 123 | Chemokine signaling pathway_Homo sapiens_hsa04062 | -0.0085993 |
| 124 | Tuberculosis_Homo sapiens_hsa05152 | -0.0032980 |
| 125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0009910 |

